However, since this study is only a case report, whether ILD in this case is caused by savolitinib itself or the combination of 2 drugs increases the risk of ILD caused by EGFR-TKI is unclear, and further confirmation is needed in high-quality clinical studies. Here, EGFR is linked to interstitial lung disease.